
Human iPSC-derived Pancreatic Islet Organoid
These organoids model human pancreatic islet biology, consisting of insulin-producing β-cells along with α- and δ-cell populations. They display glucose responsiveness and insulin secretion dynamics, providing a physiologically relevant model for diabetes research, drug screening, and regenerative medicine.
Benefits
- Functional β-cell–rich organoids with glucose-stimulated insulin secretion
- Multi-lineage representation (α, β, δ cells)
- Enables diabetes modeling, drug evaluation, and regenerative studies
Product Specifications
Feature |
Detail |
---|---|
Identity Markers |
Insulin (INS), Glucagon (GCG), Somatostatin (SST), NKX6.1, PDX1 |
Quantities |
≥ 5 × 10⁵ cells per organoid |
Quality Control |
Glucose-stimulated insulin secretion, viability, cell composition (FACS), mycoplasma testing |
Format |
Cryopreserved islet organoids |
Donor & Reprogramming |
Healthy or diabetic donor lines; Sendai virus reprogramming |
Shipping / Storage |
Dry shipper at -180°C to -135°C |
Supplied with |
Pancreatic islet culture medium and user-guide |
Explore Pancreatic Islet Organoid
Discover our high-purity, iPSC-derived ventricular cardiomyocytes designed for cardiac safety, electrophysiology, and drug discovery research. Check out the product details to see how these cells can accelerate your studies.